A Study of the Safety of Gabapentin in a Potential Over-the-Counter Population With Occasional Sleeplessness
Status:
Completed
Trial end date:
2005-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety of gabapentin, as compared to placebo, in a
potential over-the-counter population with reports of occasional sleeplessness
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.